Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has licensed Adasuve for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults from Alexza Pharmaceuticals Inc. (Nasdaq: ALXA) for up to $235 million before royalties. Teva will be the exclusive licensee of the drug in the US.
Bipolar Tips and Guide to the signs, treatment & symptoms of bipolar disorder. Learn about triggers, risk factors, and how to help yourself To find out more information about schizophrenia please visit http://mybrainsick.com.
- Health Activist Hero Nominee - Chrisa constantly advocates for her own children and others in the mental health community. She is not afraid to take on others in order to erase the stigma that still surrounds mental illness.